Cell and Gene Therapy, Industry
July 21, 2021
Via: Contract PharmaAsklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, was granted Fast Track Designation from the FDA for the LION-101 gene therapy program. LION-101 is a novel recombinant adeno-associated virus (rAAV) based vector being developed as a one-time intravenous infusion […]
Cell and Gene Therapy, Industry, Mergers and Acquisitions
October 28, 2020
Via: Contract PharmaBayer AG has acquired Asklepios BioPharmaceutical, Inc. (AskBio) for $2 billion upfront and potential success-based milestone payments of up to $2 billion. The U.S.-headquartered biopharma specializes in the research, development and manufacturing of gene therapies across different therapeutic areas. AskBio’s […]
September 21, 2023
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 1, 2023
August 30, 2023
September 19, 2023
Copyright © 2023. All rights reserved
